Mark Walport

32.2k total citations · 6 hit papers
319 papers, 22.7k citations indexed

About

Mark Walport is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Walport has authored 319 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Immunology, 86 papers in Rheumatology and 68 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Walport's work include Complement system in diseases (95 papers), Systemic Lupus Erythematosus Research (78 papers) and Monoclonal and Polyclonal Antibodies Research (64 papers). Mark Walport is often cited by papers focused on Complement system in diseases (95 papers), Systemic Lupus Erythematosus Research (78 papers) and Monoclonal and Polyclonal Antibodies Research (64 papers). Mark Walport collaborates with scholars based in United Kingdom, United States and Switzerland. Mark Walport's co-authors include Marina Botto, H. Terence Cook, Kevin Davies, Anne E. Bygrave, Matthew C. Pickering, John Savill, Philip R. Taylor, J E Henson, Chris Haslett and A H Wyllie and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Walport

314 papers receiving 22.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement

2001 2.3k citations Mark Walport profile →
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

1989 1.3k citations John Savill, A H Wyllie et al. Journal of Clinical Investigation profile →
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1998 1.2k citations Marina Botto, Anne E. Bygrave et al. profile →
Complement

2001 1.1k citations Mark Walport profile →
A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo

2000 580 citations Philip R. Taylor, Valerie A. Fadok et al. profile →
Arthritis Critically Dependent on Innate Immune System Players

2002 563 citations Mark Walport et al. profile →

Peers

Countries citing papers authored by Mark Walport

Since Specialization

Citations

This map shows the geographic impact of Mark Walport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Walport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Walport more than expected).

Fields of papers citing papers by Mark Walport

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Walport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Walport. The network helps show where Mark Walport may publish in the future.

Co-authorship network of co-authors of Mark Walport

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Walport. A scholar is included among the top collaborators of Mark Walport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Walport. Mark Walport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and Characterization of a Lupus Suppressor 129 Locus on Chromosome 3 2010 ·The Journal of Immunology ·Francesco Carlucci, Liliane Fossati‐Jimack, Ingrid E. Dumitriu, (unknown), Mark Walport, (unknown), Paramita Baruah, Oliver A. Garden, H. Terence Cook, Marina Botto	11
2	Genetic Dissection of Spontaneous Autoimmunity Driven by 129-Derived Chromosome 1 Loci When Expressed on C57BL/6 Mice 2007 ·The Journal of Immunology ·Francesco Carlucci, Josefina Cortés-Hernández, Liliane Fossati‐Jimack, Anne E. Bygrave, Mark Walport, Timothy J. Vyse, H. Terence Cook, Marina Botto	54
3	Increased Positive Selection of B1 Cells and Reduced B Cell Tolerance to Intracellular Antigens in c1q-Deficient Mice 2007 ·The Journal of Immunology ·Helen Ferry, Paul Potter, Tanya L. Crockford, Anastasia Nijnik, Michael R. Ehrenstein, Mark Walport, Marina Botto, Richard J. Cornall	27
4	Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice 2006 ·Proceedings of the National Academy of Sciences ·Matthew C. Pickering, Joanna Warren, Kamala Rose, Francesco Carlucci, (unknown), Mark Walport, H. Terence Cook, Marina Botto	120
5	A Novel Mechanism for Complement Activation at the Surface of B Cells Following Antigen Binding 2006 ·The Journal of Immunology ·Anthony P. Manderson, Ben Quah, Marina Botto, Christopher C. Goodnow, Mark Walport, Christopher R. Parish	7
6	Murine CD93 (C1qRp) Contributes to the Removal of Apoptotic Cells In Vivo but Is Not Required for C1q-Mediated Enhancement of Phagocytosis 2004 ·The Journal of Immunology ·Peter J. Norsworthy, Liliane Fossati‐Jimack, Josefina Cortés-Hernández, Philip R. Taylor, Anne E. Bygrave, R. Thompson, Sussan Nourshargh, Mark Walport, Marina Botto	116
7	Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells 2003 ·The Journal of Immunology ·Paul Potter, Josefina Cortés-Hernández, Pierre Quartier, Marina Botto, Mark Walport	142
8	Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex 2002 ·The Journal of Immunology ·R. William Vandivier, Carol Anne Ogden, Valerie A. Fadok, Peter R. Hoffmann, Kevin K. Brown, Marina Botto, Mark Walport, James H. Fisher, Peter M. Henson, Kelly E. Greene	420
9	AA amyloid deposition is complement independent 2001 ·UCL Discovery (University College London) ·(unknown), (unknown), Marina Botto, Mark Walport, (unknown)	1
10	Autoantigen Glycoprotein 70 Expression Is Regulated by a Single Locus, Which Acts as a Checkpoint for Pathogenic Anti-Glycoprotein 70 Autoantibody Production and Hence for the Corresponding Development of Severe Nephritis, in Lupus-Prone BXSB Mice1 2001 ·The Journal of Immunology ·Michelle E. K. Haywood, Timothy J. Vyse, (unknown), E. Mary Thompson, Akinori Ida, Mark Walport, Shozo Izui, Bernard J. Morley	31
11	Reconstitution of the Complement Function in C1q-Deficient (C1qa−/−) Mice with Wild-Type Bone Marrow Cells 2001 ·The Journal of Immunology ·Franz Petry, Marina Botto, Rafaela Holtappels, Mark Walport, Michael Loos	96
12	Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice 2000 ·Arthritis & Rheumatism ·Michelle E. K. Haywood, Maxine Hogarth, (unknown), S. J. Rose, (unknown), E. Mary Thompson, (unknown), Phillip Chandler, Kevin Davies, Elizabeth Simpson, Mark Walport, Bernard J. Morley	69
13	B cell tolerance is intact in C1q deficient mice 1999 ·Molecular Immunology ·Antony J. Cutler, Richard J. Cornall, H. E. Street, Marina Botto, Mark Walport	1
14	Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing 1990 ·The Lancet ·S Levi, Mark Walport, H J Hodgson, Robert A. Goodlad, Chin‐Yun Lee, (unknown), Nicholas A. Wright	149
15	Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. breakdown → 1989 ·Journal of Clinical Investigation ·John Savill, A H Wyllie, J E Henson, Mark Walport, P M Henson, Chris Haslett	1303
16	Clinical and immunologic features of livedo reticularis in lupus: A case-control study 1989 ·The American Journal of Medicine ·H. Englert, S. Loizou, G. Derue, Mark Walport, Graham R.V. Hughes	5
17	The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. 1988 ·The Journal of Immunology ·Jürg A. Schifferli, Y C Ng, J Estreicher, Mark Walport	123
18	Livedo reticularis and lupus erythematosus clinical and immunological associations 1986 ·Lara D. Veeken ·H. Englert, S. Loizou, G R Hughes, V R Aber, Mark Walport	1
19	Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. 1983 ·BMJ ·A.H.L. Fielder, Mark Walport, J. R. Batchelor, Richard I. Rynes, C. M. Black, I. Anthony Dodi, G. R. V. Hughes	363
20	Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide 1982 ·BMJ ·Mark Walport, W N Hubbard, Graham R.V. Hughes	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact